Prof. Moussa Youdim with the drug he developed.
Prof. Moussa Youdim with the drug he developed. Photo by Nati Shohat

• Technion Prof. Moussa Youdim publishes a paper claiming the compound Rasagiline can fight Parkinson’s disease. Three years later, Israeli drug company Teva Pharmaceuticals develops Azilect and begins marketing it in Europe (2005) and the United States (2006).

• Jerusalem celebrates its 3,000th anniversary of King David establishing it as his capital city.